Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma
- PMID: 17912010
- DOI: 10.1159/000108963
Cancer risk among the relatives of patients with pancreatic ductal adenocarcinoma
Abstract
Background/aims: Pancreatic cancer is a leading cause of cancer-related death; the most consistently identified risk factors are smoking and family history. Our aims were to examine familial aggregations of pancreas and other cancers, and to determine the relative risk of the family members.
Methods: We prospectively collected data on the families of patients presenting with pancreatic ductal adenocarcinoma. Smoking habits and alcohol consumption of the probands were compared with the available statistics on the Italian population. Mortality from cancer was investigated in first-degree relatives, and age-dependent risks of dying from pancreatic cancer and other tumors were compared with background population levels.
Results: Data for 570 families were collected, including 9,204 relatives. Probands were 3- to 5-fold more often heavy smokers than the general population, and 9.3% of them reported a positive family history of pancreatic cancer. In first-degree relatives, only mortality from pancreatic cancer was significantly increased (relative risk at age 85 years = 2.7). Lifetime risk of dying of pancreas cancer was 4.1% for the relatives of all probands, and was 7.2% for the relatives of probands who developed disease before 60 years of age.
Conclusions: The data suggest that genetic susceptibility to pancreatic cancer may be attributable, in addition to BRCA2, to moderate- to low-penetrance gene(s).
(c) 2007 S. Karger AG, Basel and IAP.
Similar articles
-
Risk for smoking-related cancer among relatives of lung cancer patients.Cancer Res. 2003 Dec 1;63(23):8531-5. Cancer Res. 2003. PMID: 14679021
-
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.Clin Cancer Res. 2001 Mar;7(3):738-44. Clin Cancer Res. 2001. PMID: 11297271
-
Family history and the risk of liver, gallbladder, and pancreatic cancer.Cancer Epidemiol Biomarkers Prev. 1994 Apr-May;3(3):209-12. Cancer Epidemiol Biomarkers Prev. 1994. PMID: 8019368
-
Genetic susceptibility in pancreatic ductal adenocarcinoma.Br J Surg. 2008 Jan;95(1):22-32. doi: 10.1002/bjs.6049. Br J Surg. 2008. PMID: 18076020 Review.
-
Rare ductal adenocarcinoma of the pancreas in patients younger than age 40 years.Cancer. 2004 Jan 1;100(1):173-82. doi: 10.1002/cncr.11860. Cancer. 2004. PMID: 14692038 Review.
Cited by
-
Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro.World J Gastroenterol. 2008 Apr 21;14(15):2358-63. doi: 10.3748/wjg.14.2358. World J Gastroenterol. 2008. PMID: 18416462 Free PMC article.
-
Familial Pancreatic Cancer and Surveillance of High-Risk Individuals.Gut Liver. 2019 Sep 15;13(5):498-505. doi: 10.5009/gnl18449. Gut Liver. 2019. PMID: 30917631 Free PMC article. Review.
-
Familial pancreatic cancer--status quo.Int J Colorectal Dis. 2014 Feb;29(2):139-45. doi: 10.1007/s00384-013-1760-3. Epub 2013 Aug 16. Int J Colorectal Dis. 2014. PMID: 23948969 Review.
-
Family history of cancer and tobacco exposure in index cases of pancreatic ductal adenocarcinoma.J Oncol. 2011;2011:215985. doi: 10.1155/2011/215985. Epub 2011 Apr 6. J Oncol. 2011. PMID: 21547248 Free PMC article.
-
Is intraductal tubulopapillary neoplasia a new entity in the spectrum of familial pancreatic cancer syndrome?Fam Cancer. 2014 Jun;13(2):227-9. doi: 10.1007/s10689-013-9696-x. Fam Cancer. 2014. PMID: 24317685
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous